Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pimecrolimus and Epidermal Barrier Function

This study has been completed.
Sponsor:
Collaborators:
Deutsche Forschungsgemeinschaft, Bonn, Germany
Novartis Pharma GmbH, Nürnberg, Germany
Information provided by:
University of Kiel
ClinicalTrials.gov Identifier:
NCT01132079
First received: May 26, 2010
Last updated: NA
Last verified: March 2005
History: No changes posted